Royal Fund Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,600
Closed -$40.9K 345
2026
Q1
$40.9K Buy
+1,600
New +$228K ﹤0.01% 283
2025
Q3
Sell
-13,100
Closed -$1.18M 357
2025
Q2
$1.18M Sell
13,100
-300
-2% -$23.7K 0.12% 180
2025
Q1
$780K Buy
+13,400
New +$1.24M 0.09% 213
2024
Q4
Sell
-19,000
Closed -$995K 371
2024
Q3
$995K Sell
19,000
-1,500
-7% -$70.4K 0.06% 217
2024
Q2
$1.24M Buy
+20,500
New +$1.42M 0.1% 175

Other funds holding ALAB

Royal Fund Management's ALAB Position: Q2 2026 in Review

Royal Fund Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 2,300 shares — an estimated $252K sold.

Royal Fund Management first reported a position in ALAB in Q4 2024 and held it in 4 quarters. The position peaked at $1.61M in Q2 2025. 225 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Royal Fund Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Royal Fund Management sold 2,300 Astera Labs shares in Q2 2026, an estimated $252K.
  • Royal Fund Management first reported a position in Astera Labs in Q4 2024 and held it in 4 quarters.
  • Royal Fund Management's Astera Labs position peaked at $1.61M in Q2 2025.
  • 225 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.